2026-09-30 · 2026-09 / week-5
Cal-Maine’s Egg Supply Is Growing; the Short Still Fails 10/5
Cal-Maine’s Egg Supply Is Growing; the Short Still Fails 10/5
Summary: USDA’s latest monthly report shows August U.S. table-egg output up 6% year over year, while Cal-Maine’s FY26 filing attributes a sharp earnings contraction to low, supply-led prices. But CALM has already fallen 13% from its Sep. 1 close, trades close to its recent low, and entered the quarter with $924 million of cash and short-term investments. The Q1 release may move the stock, but the highest-probability reference path is flat and the adverse stress is more than 5%. Reject / no trade.
Opportunity Ranking
This U.S.-only short screen compares Cal-Maine’s commodity-supply exposure with Jabil’s AI-linked manufacturing growth and FactSet’s subscription/margin bridge. SPY is a broad-market reference, not an issuer-specific short thesis.
| Rank | Candidate | Direction | Mispricing | Evidence Freshness | Catalyst Window | Positioning | 10/5 Status | Tradeability | Main Rejection Risk |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Cal-Maine Foods (CALM) | Short | USDA table-egg supply is rising while CALM’s FY26 conventional-shell segment recorded a Q4 operating loss; at $68.55, however, the stock is already 13% below its Sep. 1 close and near a recent low | USDA Sep. 21 monthly release; CALM FY26 10-K / Q4 release; Sep. 29 close | FY27 Q1 release scheduled about 6:00 a.m. ET Sep. 30; call at 9:00 a.m. ET | Current short interest, borrow, utilization, recall, and options positioning not verified | Reject: highest-probability base decline 0%; recent-low top case only 2.8%; upside stress +15.3% | Nasdaq common; Sep. 29 close and extended-hours context only; no live spread, depth, locate, or exit audit | The price already reflects a large earnings reset; $924M of cash/short-term investments, specialty eggs and prepared foods, or an HPAI supply shock can support a rebound |
| 2 | Jabil (JBL) | Short | Q3 beat and raised FY26 outlook on strong AI-infrastructure demand; its Sep. 30 print could disappoint, but no fresh downside evidence is verified before results | Jun. 17 Q3 release; Sep. 9 date notice; Sep. 30 premarket finance feed | FY26 results before the open; 8:30 a.m. ET call | Positioning and borrow not verified | Reject pending report: no sourced 10% base decline or +5% adverse cap | NYSE common, high apparent normal turnover; current order book and post-result exit capacity not audited | AI-related demand may keep growing and guidance may rise again; the earnings gap cuts both ways |
| 3 | FactSet Research Systems (FDS) | Short | Q3 revenue grew 7.1% and organic ASV 6.7%, but operating margins contracted; the Q4 webcast is today, with no verified estimate reset large enough to support a short | Jul. 1 Q3 release; Sep. 14 event notice; Sep. 29 price/extended-hours feed | Q4 webcast at 9:00 a.m. ET Sep. 30 | Positioning and borrow not verified | Reject pending report: no issuer-specific 10/5 map | NYSE/Nasdaq common; normal liquidity is substantial but current execution gates unverified | Recurring subscriptions and a product/data franchise can sustain growth despite margin pressure |
| 4 | SPDR S&P 500 ETF (SPY) | Short | The broad index was modestly lower in the Sep. 29 session; no issuer-specific catalyst supports a 10% two-day downside case | Sep. 29 close and Sep. 30 premarket finance feed | Rates and macro data; no single issuer catalyst | Index positioning not reviewed | Reject: no evidenced short edge | Highly liquid in regular hours; no order-book audit | Any easing in rates or risk premia could reverse a modest pullback |
Selected opportunity: CALM for information value only, not as the best executable short.
Why this one now: The Sep. 21 USDA release provides a fresh upstream supply check immediately before Cal-Maine’s Q1 report. It updates the older FY26 supply explanation with August production and the Sep. 1 layer count.
What should surprise the reader: The operating short case is real, but the stock’s quote is not a blank slate: it is 13.2% below the Sep. 1 close, only 2.8% above the Sep. 25 intraday low, and CALM’s own IR snapshot reports $924M of cash and short-term investments at May 30. That is not a floor; it makes a further 10% base decline difficult to underwrite from this evidence.
Why CALM Ranks First for Information Value
Fact: USDA NASS reported 8.122 billion table eggs produced in August 2026, 6% above August 2025. The Sep. 1 table-egg layer flock was 318.7 million, also 5% above a year earlier. These are national totals, not Cal-Maine-specific production or a direct wholesale price forecast.
Fact: CALM’s FY26 release reported $2.912B net sales, down 31.7%; $672M gross profit, down 63.7%; $350M operating income, down 77.2%; and diluted EPS of $6.63 versus $24.95. Q4 alone produced a $35.9M net loss and -$0.76 diluted EPS. Management attributed the conventional-shell decline to elevated supply and prices at historically low inflation-adjusted levels. It also noted that fiscal Q1 and Q4 are seasonally the lowest pricing periods.
The price-to-reality disagreement is narrow: public supply remained high into the quarter, yet the equity had already sold off sharply. MarketBeat’s Sep. 30 event page listed a compiled Q1 consensus of -$0.77 EPS and $561.6M revenue; that is secondary consensus data with no independently validated analyst count or estimate dispersion. The market appears to expect a loss, not a return to the prior shortage-driven profit peak. A worse result could matter, but “egg supply is high” alone does not establish an incremental surprise of the size required for a short.
Why This Can Move More Than 5% Soon
CALM’s report is scheduled before the U.S. open, followed by a 9:00 a.m. ET webcast. Another loss, continued non-payment under the variable-dividend policy, or weak shell-egg realization could move the shares. A contrary surprise is equally plausible: volume/mix, grain-linked pricing, prepared-foods execution, or new HPAI losses could lift expected margins. These are event-risk paths, not evidence of directional edge.
The regular close was already near a recent low. MarketBeat’s history lists $68.55 at 4:00 p.m. EDT Sep. 29, after a $66.88-$68.85 session range. Its latest extended-hours reference was $68.64 at 7:59 p.m. EDT. The map below uses the regular close; the extended-hours observation is reference-only and is not an entry.
10/5 Asymmetry Gate
The reference-only event map runs through Oct. 2, 2026. Its levels are observed market references, not fair value, price targets, floors, or caps. The reference is $68.55 at the Sep. 29 regular close (4:00 p.m. EDT / 20:00 UTC). MarketBeat lists a $66.62 Sep. 25 intraday low and a $79.02 Sep. 1 close. Probabilities are analyst judgments, not observed frequencies: the largest weight goes to a flat response because the public record already reflects a severe earnings reset and the secondary consensus expects a loss; the two tails split between a retest of the recent low and a rebound toward an earlier close.
| Scenario | Probability | Target / Level | Short Return from $68.55 | Horizon | Conditions | Evidence Quality |
|---|---|---|---|---|---|---|
| Top Case | 25% | $66.62 | +2.8% | Through Oct. 2, 2026 | A weak release prompts a retest of the Sep. 25 intraday low | Low; observed level, subjective probability |
| Base Case | 50% | $68.55 | 0.0% | Through Oct. 2, 2026 | A loss broadly matches the already-negative earnings expectation; investors await price, mix, and margin evidence | Low; reference hold, not a forecast |
| Bottom Case | 25% | $79.02 | -15.3% | Through Oct. 2, 2026 | Better mix/price realization or a supply shock drives a rebound to the Sep. 1 close | Medium for the historical close; low as a forecast |
| Invalidation | n/a | Evidence trigger, not price stop | The release shows conventional-shell contribution stabilizing, specialty/prepared margins expanding, or supply falling faster than assumed | Sep. 30 release and webcast | Rebuild from actual segment prices, volumes, margins, and balance-sheet changes | Medium |
Probability-weighted expected value: $70.685 per share; -3.1% gross short return before costs: (68.55 - (0.25×66.62 + 0.50×68.55 + 0.25×79.02)) / 68.55.
Current market level and timestamp: $68.55, Sep. 29, 4:00 p.m. EDT / 20:00 UTC; regular-session close. Separate extended-hours reference: $68.64, 7:59 p.m. EDT / 23:59 UTC.
Primary instrument: CALM common stock, research only.
10/5 favorable base move: 0.0%; the 2.8% top-case decline is not the highest-probability case and is below the 10% threshold.
10/5 credible adverse move: +15.3% to the observed Sep. 1 close; not a cap.
10/5 measurement basis: Reference-only; entry.price is null.
10/5 status: Reject. Base reward/adverse ratio is 0:1, and the adverse stress exceeds 5% before borrow or execution costs.
Confidence: Low.
The Setup
Cal-Maine is the largest U.S. egg producer and sells conventional shell eggs, specialty shell eggs, and prepared foods. The FY26 release listed $924.1M of cash and short-term investments at May 30 and no debt. Conventional shell eggs generated a $40.6M Q4 segment operating loss; specialty shell eggs made $17.5M and prepared foods $8.8M. Specialty eggs plus prepared foods represented 53% of Q4 net sales, but these businesses had not yet offset the conventional-shell loss in consolidated operating income.
The issuer’s FY26 10-K says USDA counted 312.0M total layer hens on July 1, compared with a five-year average of 308.0M. The newer USDA NASS report shows the table-egg flock at 318.7M on Sep. 1. The measures are not identical: the 10-K’s figure covers total layers and its comparison is a five-year average; NASS separately reports table-egg layers and year-over-year changes. Both point to expanded supply, not a CALM-specific realized price.
The strongest counterparty case is that the headline supply glut is partly in the price already, while the equity owns an unlevered balance sheet and a larger prepared-foods platform. CALM announced additional prepared-foods capacity expected to begin in FY28; capacity is not current earnings. A new HPAI outbreak could remove hens quickly and reverse the supply outlook. That tail risk makes the bottom-case rebound credible and unbounded by the observed Sep. 1 close.
The Market Price
| Observation | Value | Timestamp | Source / limitation |
|---|---|---|---|
| Regular-session reference | $68.55 | Sep. 29, 4:00 p.m. EDT / 20:00 UTC | MarketBeat historical close; not executable |
| Session range and volume | $66.88-$68.85; 1.74M shares | Sep. 29 regular session | MarketBeat; no NBBO or venue/depth record |
| Extended-hours context | $68.64 | Sep. 29, 7:59 p.m. EDT / 23:59 UTC | MarketBeat/Massive reference; not an entry |
| Recent comparison | $79.02 close | Sep. 1, 4:00 p.m. EDT | MarketBeat; $68.55 is 13.2% lower |
| Recent downside reference | $66.62 intraday low | Sep. 25 | MarketBeat; not a floor |
The quote is about $1.93, or 2.8%, above that recent low. It is not appropriate to infer a support level from a short lookback. The secondary finance-feed snapshot lists an approximate $3.25B capitalization, while the May 30 cash balance is stale and no current share count/net-cash reconciliation is available. I do not have sufficient reliable data to derive current enterprise value or a cash-adjusted fair value accurately.
The Mispricing
Fact: The USDA’s September supply data is inconsistent with a quick, shortage-driven price recovery. Inference: conventional-shell margins may stay weak into the seasonally soft fiscal Q1 even if unit volumes hold. Counter-inference: the market already marks CALM down 13% since Sep. 1, recent price lows sit close beneath it, and the prepared-foods/specialty mix is larger than a year ago. No verified consensus dispersion or current quote-implied earnings distribution shows the stock still expects peak egg economics.
The short would need more than continued low conventional pricing: it would need an earnings or cash-flow path worse than what a loss-making Q1 consensus implies, with no offset from mix, specialty pricing, prepared-foods contribution, or an HPAI-driven supply shock. That bridge is not established before today’s report.
The Positioning
Current short interest, days-to-cover, utilization, borrow fee, recall terms, options positioning, institutional flows, and market-maker exposure were not independently verified. The Sep. 29 decline and 1.74M-share turnover do not establish a crowded short or forced seller. The positioning/flows score is therefore capped at 3/5, and the execution gate remains closed.
The Catalyst
- FY27 Q1 release: Cal-Maine scheduled the release for approximately 6:00 a.m. ET Sep. 30. Separate conventional, specialty, and prepared-foods prices, volumes, segment operating income, and any dividend decision. The call is at 9:00 a.m. ET.
- Cheapest disconfirmation: Compare reported egg supply and sales mix with the USDA Sep. 21 release. If unit/price realization and margins stabilize despite the larger national flock, the simple oversupply short is weakened.
- Next supply check: USDA NASS lists the next Chickens and Eggs report for Oct. 20. Verify the layer count, table-egg output, and placement data before assuming continued easing.
Announced: today’s Q1 event and Oct. 20 USDA release. Not yet known at the cutoff: Q1 results, post-quarter flock changes, current borrow, or the equity’s first-session response. Publication is before the scheduled report; the scenario map must be rebuilt after the release and regular-session acceptance.
The Payoff
The highest-probability price path in the reference map is flat, not a decline. Even the thesis-best observed-level case is below a 3% drop. The adverse case is a 15.3% rise to a recent close, before a more severe HPAI or squeeze scenario. Expected gross short value is negative 3.1% before borrow, spread, slippage, and fees. A hard stop would not cap a premarket gap or halt.
The Kill Shot
The mature counterparty argument is that the market has already repriced the egg shortage unwind: FY26 sales and earnings collapsed, the Q1 comparison is against a much higher price year, and published analyst consensus already expects a loss. The company’s cash balance, no-debt profile, and non-conventional mix provide time for a cycle recovery. This is not proof that the shares are cheap; it is enough to defeat a short whose base case cannot reach -10% and whose credible rebound exceeds +5%.
The load-bearing short assumption is that abundant supply persists long enough to prevent conventional contribution from recovering before specialty/prepared foods scale. The cheapest falsification is the Q1 segment bridge plus the Oct. 20 USDA flock/output report. A reported decline in supply, materially better selling prices, or broad margin stabilization invalidates the near-term oversupply case.
What Could Go Wrong
- HPAI can eliminate production capacity and reverse the supply-price path faster than quarterly reports reveal.
- Fiscal Q1 is seasonally weak, but the amount is uncertain; historical seasonal weakness does not guarantee another sequential decline.
- Prepared-foods capacity and acquired brands may add earnings resilience, while Q4 mix had already shifted materially.
- The quote is near a recent low. A short opened before a scheduled release faces gap, halt, borrow recall, and poor exit-liquidity risk.
- The $924M cash-and-short-term-investments figure is dated May 30, not a current liquidity statement; future working-capital needs and acquisitions matter.
- The observed bottom reference is not a ceiling. Actual upside can exceed the model, including beyond 5%.
What Would Prove This Wrong
The supply thesis weakens if today’s release shows positive conventional-shell contribution despite the USDA flock expansion, if specialty and prepared-foods earnings cover conventional losses without new leverage, or if the Oct. 20 NASS report shows a meaningful supply contraction. A price decline without margin/volume confirmation is not enough to validate the operating thesis.
Risk Audit
No current borrow, locate, recall, spread, depth, or exit-capacity evidence is available. No verified analyst-estimate range was obtained beyond a secondary MarketBeat consensus snapshot. The reference scenario probabilities are subjective and not calibrated; the 48-hour outcome is prospective and unscored. Recent CALM price changes do not establish short positioning. No prior CALM forecast was found in the Desk archive; the other Sep. 29/30 run horizons have not matured.
Best Trade Strategy
No trade. Keep entry.price=null, status watch for research context only, and execution.can_execute=false. Reassess only after the Q1 release, the 9:00 a.m. ET call, and first regular-session price acceptance. Any later short review must use a fresh quote, live borrow/locate and recall terms, bid/ask and depth, venue/volume quality, exit capacity, current filings, and a new downside map that clears all 10/5 gates. Do not use options, leverage, margin, market orders, or price-floor logic.
Sources
| Source | Date | Use |
|---|---|---|
| USDA NASS, Chickens and Eggs (Sep. 21) | Sep. 21, 2026 | August egg production and Sep. 1 layer counts |
| CALM FY26 Q4 results, SEC Exhibit 99.1 | Jul. 22, 2026 | Annual/Q4 sales, earnings, segment results, cash, outlook and dividend policy |
| CALM FY26 Form 10-K | Jul. 22, 2026 | Supply and seasonal operating context |
| CALM FY27 Q1 release schedule | Sep. 9, 2026 | Release and webcast timing |
| CALM price history and Q1 estimate snapshot | Checked Sep. 30 | Secondary regular close, extended reference, range, volume and analyst consensus; not execution data |
| Jabil Q3 FY26 results and Q4/FY26 event | Jun. 17 / Sep. 9 | Candidate comparison |
| FactSet Q3 FY26 results and events page | Jul. 1 / current event page | Candidate comparison |
| SPY finance-feed reference | Sep. 30 premarket | Broad-market context only |
Research Quality Scorecard
| Criterion | Score (1-5) | Evidence / deduction |
|---|---|---|
| Market disagreement | 4 | USDA supply and CALM’s loss-making conventional-shell quarter conflict with a price already near recent lows |
| Evidence base | 4 | Fresh primary USDA data, SEC release/10-K, and current event schedule; the Q1 print remains pending |
| Positioning and flows | 2 | Current short interest, borrow, options and holder flows not verified |
| Catalyst path | 4 | Scheduled release and webcast today; next USDA report dated Oct. 20 |
| Payoff architecture | 3 | Common horizon and observed levels shown; subjective weights and no responsible executable entry |
| Invalidation discipline | 4 | Segment margin, price, volume, and USDA supply tests are observable |
| Differentiated insight | 4 | Separates national supply data from CALM-specific realization and the larger non-conventional mix |
| Client value | 4 | Shows why a genuine operating risk still does not produce a 10/5 short at this quote |
| Total | 29/40 | Descriptive research score; the failed 10/5 gate forces Reject / no trade |
Bottom Line
The oversupply evidence is fresh and company earnings contracted sharply, but the short is not asymmetric here: the most likely case is flat, the best observed downside level is only 2.8% lower, and a rebound to an observed close is 15.3% higher. The scheduled report could change that boundary. Until actual segment results and first-session trading are known, the correct decision is Reject / no trade.
AI Illustration Prompt
Create a restrained, documentary-style financial research illustration for The Mispricing Desk: a quiet egg-packing facility before sunrise, with stainless conveyors and clean cartons in the background. In the foreground, place a USDA poultry statistics sheet showing “AUG 2026 TABLE EGGS 8.122B / +6% Y/Y” beside a Cal-Maine FY26 report with “CONVENTIONAL SHELL Q4 OPERATING LOSS $40.6M” and “CASH + SHORT-TERM INVESTMENTS $924.1M AT MAY 30.” Add a market terminal with two clearly separate panels: “CALM REGULAR CLOSE $68.55 / SEP 29 4:00 PM EDT” and “EXTENDED REFERENCE $68.64 / 7:59 PM EDT,” with a small rust-red stamp “ENTRY UNVERIFIED.” Show a calendar card marked “Q1 FY27 REPORT ~6:00 AM ET / WEBCAST 9:00 AM ET.” Use warm paper, restrained navy, stainless steel, pale grain-gold, and one controlled red risk accent. Premium, tactile, forensic editorial photography; no generic candlestick chart, egg-price claims beyond the printed figures, arrows, slogans, or profit promises. Add a subtle readable “The Mispricing Desk” watermark.